within Pharmacolibrary.Drugs.ATC.C;

model C08DA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.23,
    Cl             = 0.0006166666666666666,
    adminDuration  = 600,
    adminMass      = 80 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0028,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.0035,
    k12             = 22,
    k21             = 22
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C08DA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Verapamil is a calcium channel blocker used therapeutically to treat hypertension, angina pectoris, and certain arrhythmias such as supraventricular tachycardia. It is approved for use and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following a single oral dose of verapamil.</p><h4>References</h4><ol><li><p>Elazab, ST, &amp; Hsu, WH (2021). Effects of verapamil on the pharmacokinetics of ivermectin in rabbits. <i>Journal of veterinary pharmacology and therapeutics</i> 44(3) 397–405. DOI:<a href=\"https://doi.org/10.1111/jvp.12919\">10.1111/jvp.12919</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33070345/\">https://pubmed.ncbi.nlm.nih.gov/33070345</a></p></li><li><p>Yao, H, et al., &amp; Zeng, A (2020). Comparative pharmacokinetics of verapamil and norverapamil in normal and ulcerative colitis rats after oral administration of low and high dose verapamil by UPLC-MS/MS. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 50(6) 713–721. DOI:<a href=\"https://doi.org/10.1080/00498254.2019.1682715\">10.1080/00498254.2019.1682715</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31633443/\">https://pubmed.ncbi.nlm.nih.gov/31633443</a></p></li><li><p>Zhou, Y, et al., &amp; Dong, G (2019). Effects of verapamil on the pharmacokinetics of puerarin in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 49(10) 1178–1182. DOI:<a href=\"https://doi.org/10.1080/00498254.2018.1518552\">10.1080/00498254.2018.1518552</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30173622/\">https://pubmed.ncbi.nlm.nih.gov/30173622</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C08DA01;
